Physician profile
Timothy Lipp
NPI 1255863718
$2,997.76
in general payments reported to CMS, 2019-2025
9 companies · $33.74 in 2025
The $33.74 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.64 · 2020: $2,500 · 2022: $194 · 2023: $249 · 2025: $33.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,500.00 | 2020 | |
| Inari Medical, INC. | $189.79 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Intuitive Surgical, INC. | $129.74 | 2022 | |
| Glaxosmithkline, LLC. | $47.77 | 2022 | |
| Stryker Corporation | $33.74 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $32.95 | 2022-2023 | |
| Novo Nordisk INC | $22.97 | 2023 | Ozempic |
| Avanir Pharmaceuticals, INC. | $20.64 | 2019 | |
| Dynavax Technologies Corporation | $20.16 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Lipp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.